Topic Hub
8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 8 of 8 clinical reviews.
How aerobic exercise, resistance training, and weight loss affect FibroScan (VCTE) liver stiffness and CAP scores. Includes normal ranges, MASLD staging cutoffs, and clinical guidance.
Read clinical reviewCan you get a FibroScan or VCTE result without a clinic visit? Learn about at-home liver stiffness proxies, finger-prick blood tests, normal VCTE ranges, and when formal FibroScan staging matters for MASLD and resmetirom eligibility.
Read clinical reviewAge-stratified reference ranges and optimal targets for Fibroscan liver stiffness measurement (VCTE), covering MASLD staging, resmetirom indication, and longevity-medicine context by decade.
Read clinical reviewEvidence-based FibroScan (VCTE) target ranges for longevity medicine, MASLD staging, and resmetirom eligibility. Board-reviewed clinical reference with primary literature citations.
Read clinical reviewA clinician-reviewed guide to how GLP-1 agonists, resmetirom, SGLT2 inhibitors, and other agents change Fibroscan (VCTE) liver stiffness and CAP scores in MASLD, with normal ranges, optimal targets, and dosing context.
Read clinical reviewA clinician-reviewed guide to interpreting Fibroscan / VCTE liver stiffness measurements, rate-of-change benchmarks, MASLD staging cutoffs, and resmetirom prescribing criteria, with primary-source citations throughout.
Read clinical reviewBoard-reviewed guide to how food intake, fasting duration, alcohol, and diet quality affect FibroScan (VCTE) results, with normal ranges, optimal values, and clinical protocols for MASLD staging.
Read clinical reviewHow biological sex, menstrual cycle phase, and hormone therapy affect FibroScan (VCTE) liver stiffness and CAP scores. Includes normal ranges, optimal targets, and clinical guidance for MASLD staging.
Read clinical review